BIO Brings Lawton In-House As VP-Reg Affairs/Counsel: PDUFA III Looms
Executive Summary
Biotechnology Industry Organization VP-Regulatory Affairs Stephan Lawton will focus on the reauthorization of the Prescription Drug User Fee Act upon joining the association on Jan. 1, 2001.
You may also be interested in...
BIO Seeking Regulatory Affairs Head, Gets Friendly Face In House Committee
The Biotechnology Industry Organization is conducting a search for a new vice president of regulatory affairs
BIO Seeking Regulatory Affairs Head, Gets Friendly Face In House Committee
The Biotechnology Industry Organization is conducting a search for a new vice president of regulatory affairs
BIO VP-Health Policy Cohen Joins From HIAA To Handle Medicare Rx Policy
The Biotechnology Industry Organization is gearing up for a more active role in the Medicare Rx debate in 2001 by recruiting HIAA chief lobbyist Sharon Cohen to serve as VP-health policy.